Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures

Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures

INTRODUCTION A recombinant form of activated factor VII (rFVIIa) is a haemostatic drug that is approved for use in haemophiliacs with antibodies to factor VIII or factor IX. Most recent studies and clinical experience have shown that rFVIIa (NovoSeven ®, Novo Nordisk A/S, Denmark) gives extreme haem...

Full description

Bibliographic Details
Main Authors: Končar Igor B., Savić Nebojša, Davidović Lazar B., Simić Dušica, Marković Dejan, Sinđelić Radomir B.
Format: Article
Language:English
Published: Serbian Medical Society 2008-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
recombinant activated factor VII (rFVIIa)
intractablenon-surgical bleeding
vascular surgery
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2008/0370-81790808367K.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0370-8179/2008/0370-81790808367K.pdf

Similar Items